p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.
Luo YD, Fang L, Yu HQ, Zhang J, Lin XT, Liu XY, Wu D, Li GX, Huang D, Zhang YJ, Chen S, Jiang Y, Shuai L, He Y, Zhang LD, Bie P, Xie CM.
Luo YD, et al. Among authors: shuai l.
J Hepatol. 2021 Jan;74(1):96-108. doi: 10.1016/j.jhep.2020.07.036. Epub 2020 Jul 29.
J Hepatol. 2021.
PMID: 32738450
Free article.